1. Home
  2. APOG vs EMBC Comparison

APOG vs EMBC Comparison

Compare APOG & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APOG
  • EMBC
  • Stock Information
  • Founded
  • APOG 1949
  • EMBC 1924
  • Country
  • APOG United States
  • EMBC United States
  • Employees
  • APOG N/A
  • EMBC N/A
  • Industry
  • APOG Auto Parts:O.E.M.
  • EMBC Medical/Dental Instruments
  • Sector
  • APOG Consumer Discretionary
  • EMBC Health Care
  • Exchange
  • APOG Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • APOG 818.5M
  • EMBC 726.8M
  • IPO Year
  • APOG N/A
  • EMBC N/A
  • Fundamental
  • Price
  • APOG $43.21
  • EMBC $10.25
  • Analyst Decision
  • APOG Hold
  • EMBC Hold
  • Analyst Count
  • APOG 1
  • EMBC 3
  • Target Price
  • APOG $45.00
  • EMBC $17.00
  • AVG Volume (30 Days)
  • APOG 333.4K
  • EMBC 701.8K
  • Earning Date
  • APOG 06-27-2025
  • EMBC 08-08-2025
  • Dividend Yield
  • APOG 2.41%
  • EMBC 5.87%
  • EPS Growth
  • APOG N/A
  • EMBC N/A
  • EPS
  • APOG 2.36
  • EMBC 0.89
  • Revenue
  • APOG $1,376,100,000.00
  • EMBC $1,079,500,000.00
  • Revenue This Year
  • APOG $4.04
  • EMBC N/A
  • Revenue Next Year
  • APOG N/A
  • EMBC N/A
  • P/E Ratio
  • APOG $18.25
  • EMBC $11.47
  • Revenue Growth
  • APOG N/A
  • EMBC N/A
  • 52 Week Low
  • APOG $37.53
  • EMBC $9.20
  • 52 Week High
  • APOG $87.93
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • APOG 63.84
  • EMBC 49.74
  • Support Level
  • APOG $38.16
  • EMBC $9.20
  • Resistance Level
  • APOG $49.99
  • EMBC $10.39
  • Average True Range (ATR)
  • APOG 1.92
  • EMBC 0.47
  • MACD
  • APOG 0.53
  • EMBC 0.11
  • Stochastic Oscillator
  • APOG 45.59
  • EMBC 88.61

About APOG Apogee Enterprises Inc.

Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: